|
Gynazole·1® (butoconazole nitrate) Vaginal Cream, 2%, indicated for vulvovaginal candidiasis caused by all Candida species, has demonstrated 94% clinical efficacy against yeast infections.1 |
| Gynazole·1 is the one-dose prescription vaginal yeast infection treatment that comes in a premeasured, prefilled, disposable applicator. The specially designed, multiport applicator effectively delivers Gynazole-1 to all surfaces of the vaginal wall.
|
Exclusive bioadhesion technology keeps Gynazole·1 at the site of the infection
|
|
|
Extended release allows for effective single-dose treatment, without doubling or tripling of drug concentration
|
|
|
Gynazole·1 stays at the site of the infection for a median of 4.2 days, resulting in minimal leakage2
|
|
|
One anytime dose and less mess for increased compliance3,4 |
|
|
The only single-dose cream that can be administered any time of the day or night2,5 |
|
|
Prefilled disposable applicator for easy dosing, less mess, and less hassle
|
|
Gynazole·1
is indicated for the local treatment of vulvovaginal candidiasis (infections caused
by Candida). The diagnosis should be confirmed by KOH smears and/or cultures. Note:
Gynazole·1 is safe and effective in non-pregnant women; however, the safety and
effectiveness of this product in pregnant women has not been established. |
|
|
|
|
|
|
|
|